Comparison of cardiovascular risk factors and drug use in 14,544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial disease

Atherothrombosis is a systemic disease affecting coronary, cerebral, and lower limb arteries, and requiring secondary prevention measures. Data from three observational studies carried out in 1999-2000 (ECLAT1, APRES, PRISMA) were pooled to describe the prevalence of cardiovascular risk factors and...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of cardiovascular prevention and rehabilitation Vol. 11; no. 5; pp. 394 - 402
Main Authors:	Bongard, Vanina, Cambou, Jean-Pierre, Lezorovcz, Alain, Ferrères, Jean, Vahanan, Alec, Jullen, Gérard, Coppe, Gérard, Guerllot, Martine, Herrmann, Marie-Annick, Mas, Jean-Louis
Format:	Journal Article
Language:	English
Published:	England 01-10-2004
Subjects:	Adult Aged Brain Ischemia - drug therapy Brain Ischemia - etiology Cardiovascular Agents - therapeutic use Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Female France - epidemiology Humans Hypercholesterolemia - complications Hypercholesterolemia - epidemiology Hypertension - complications Hypertension - epidemiology Life Style Male Middle Aged Myocardial Infarction - drug therapy Myocardial Infarction - etiology Peripheral Vascular Diseases - drug therapy Peripheral Vascular Diseases - etiology Prevalence Risk Factors Smoking - adverse effects Smoking - epidemiology Stroke - drug therapy Stroke - etiology France
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Atherothrombosis is a systemic disease affecting coronary, cerebral, and lower limb arteries, and requiring secondary prevention measures. Data from three observational studies carried out in 1999-2000 (ECLAT1, APRES, PRISMA) were pooled to describe the prevalence of cardiovascular risk factors and the patterns of drug use in atherothrombotic patients. General practitioners and cardiologists engaged in a private practice and evenly distributed in France recruited consecutive patients who had a history of at least one atherothrombotic event: myocardial infarction (MI), ischaemic stroke, and/or peripheral arterial disease (PAD). The sample was composed of 14 544 patients (men: 75.0%, age 75 or older: 31.0%). At least one of the four major risk factors (smoking, hypertension, hypercholesterolaemia, diabetes) was present in 94.3% of the sample. Prevalence of drug use was: 78.8% (antiplatelet agents), 48.5% (statins), 36.7% (beta-blockers), and 33.4% [angiotensin-converting enzyme (ACE) inhibitors]. After adjustment for confounders, statins were taken in a significantly larger extent in patients with a history of isolated MI than in those with a previous ischaemic stroke or PAD, or in patients who suffered from both MI and ischaemic stroke. Isolated MI (as compared with ischaemic stroke and PAD) was significantly and independently associated with a higher probability to take antiplatelet agents, beta-blockers or ACE inhibitors. At least one conventional risk factor was observed in almost all atherothrombotic patients. Use of preventive drugs was lower in patients with a history of ischaemic stroke or PAD, and should increase, accordingly to the results of recent randomized controlled trials.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1741-8267
DOI:	10.1097/00149831-200410000-00006